Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiago R Matos

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
JCI Insight|November 5, 2016
Low-dose IL-2 selectively activates subsets of CD4<sup>+</sup> Tregs and NK cellsMasahiro Hirakawa, Tiago R Matos, Hongye Liu, et al.
Blood|June 2, 2016
Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicityBenjamin L Lampson, Siddha N Kasar, Tiago R Matos, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2018
Phase I/II Trial of a Combination of Anti-CD3/CD7 Immunotoxins for Steroid-Refractory Acute Graft-versus-Host DiseaseChristoph Groth, Lenneke F J van Groningen, Tiago R Matos, et al.
The Journal of Clinical Investigation|June 10, 2020
Peripheral host T cells survive hematopoietic stem cell transplantation and promote graft-versus-host diseaseSherrie J Divito, Anders T Aasebø, Tiago R Matos, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
JCI Insight|November 5, 2016
Low-dose IL-2 selectively activates subsets of CD4<sup>+</sup> Tregs and NK cellsMasahiro Hirakawa, Tiago R Matos, Hongye Liu, et al.
Blood|June 2, 2016
Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicityBenjamin L Lampson, Siddha N Kasar, Tiago R Matos, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2018
Phase I/II Trial of a Combination of Anti-CD3/CD7 Immunotoxins for Steroid-Refractory Acute Graft-versus-Host DiseaseChristoph Groth, Lenneke F J van Groningen, Tiago R Matos, et al.
The Journal of Clinical Investigation|June 10, 2020
Peripheral host T cells survive hematopoietic stem cell transplantation and promote graft-versus-host diseaseSherrie J Divito, Anders T Aasebø, Tiago R Matos, et al.
Pageof 4